Skip to content
10-Q

Quarterly Report

BIOSPECIFICS TECHNOLOGIES CORP

0001558370-20-010124

← back to feed
Filed
Aug 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 7, 2020 7.34M sh
Shares Diluted Q2 2020 · Jun 30, 2020 7.36M sh
Shares Diluted Q2 2020 · Jun 30, 2020 7.36M sh
Shares Diluted Q2 2020 · Jun 30, 2019 7.35M sh
Shares Diluted Q2 2020 · Jun 30, 2019 7.34M sh
Stock Repurchased Q2 2020 · Jun 30, 2020 $412.76K
Stock Repurchased Q2 2020 · Jun 30, 2019 $118.57K
Capex Q2 2020 · Jun 30, 2020 $69.47K
Operating Cash Flow Q2 2020 · Jun 30, 2020 $14.83M
Operating Cash Flow Q2 2020 · Jun 30, 2019 $9.83M
Short Term Investments Q2 2020 · Jun 30, 2020 $82.18M
Short Term Investments Q2 2020 · Dec 31, 2019 $84.24M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $16.87M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $5M
Stockholders Equity Q2 2020 · Jun 30, 2020 $129.42M
Stockholders Equity Q2 2020 · Mar 31, 2020 $129.27M
Stockholders Equity Q2 2020 · Dec 31, 2019 $124.49M
Stockholders Equity Q2 2020 · Jun 30, 2019 $110.31M
Stockholders Equity Q2 2020 · Mar 31, 2019 $102.21M
Stockholders Equity Q2 2020 · Dec 31, 2018 $97.59M
Current Liabilities Q2 2020 · Jun 30, 2020 $3.84M
Current Liabilities Q2 2020 · Dec 31, 2019 $1.42M
Total Liabilities Q2 2020 · Jun 30, 2020 $4.36M
Total Liabilities Q2 2020 · Dec 31, 2019 $2.16M
Current Assets Q2 2020 · Jun 30, 2020 $112.06M
Current Assets Q2 2020 · Dec 31, 2019 $109.27M
Total Assets Q2 2020 · Jun 30, 2020 $133.78M
Total Assets Q2 2020 · Dec 31, 2019 $126.65M
Eps Diluted Q2 2020 · Jun 30, 2020 $0.02
Eps Diluted Q2 2020 · Jun 30, 2020 $0.63
Eps Diluted Q2 2020 · Jun 30, 2019 $0.87
Eps Diluted Q2 2020 · Jun 30, 2019 $1.48
Eps Basic Q2 2020 · Jun 30, 2020 $0.02
Eps Basic Q2 2020 · Jun 30, 2020 $0.63
Eps Basic Q2 2020 · Jun 30, 2019 $0.88
Eps Basic Q2 2020 · Jun 30, 2019 $1.49
Sga Expense Q2 2020 · Jun 30, 2020 $3.99M
Sga Expense Q2 2020 · Jun 30, 2020 $7.16M
Sga Expense Q2 2020 · Jun 30, 2019 $1.73M
Sga Expense Q2 2020 · Jun 30, 2019 $4.64M
Rd Expense Q2 2020 · Jun 30, 2020 $160.46K
Rd Expense Q2 2020 · Jun 30, 2020 $282.43K
Rd Expense Q2 2020 · Jun 30, 2019 $161.32K
Rd Expense Q2 2020 · Jun 30, 2019 $310.86K
Net Income Q2 2020 · Jun 30, 2020 $115.8K
Net Income Q2 2020 · Jun 30, 2020 $4.61M
Net Income Q2 2020 · Jun 30, 2019 $6.43M
Net Income Q2 2020 · Jun 30, 2019 $10.84M
Operating Income Q2 2020 · Jun 30, 2020 −$250.92K
Operating Income Q2 2020 · Jun 30, 2020 $4.98M
Operating Income Q2 2020 · Jun 30, 2019 $6.96M
Operating Income Q2 2020 · Jun 30, 2019 $12.04M
Revenue Q2 2020 · Jun 30, 2020 $3.9M
Revenue Q2 2020 · Jun 30, 2020 $13.57M
Revenue Q2 2020 · Jun 30, 2019 $8.85M
Revenue Q2 2020 · Jun 30, 2019 $16.98M